Radcliffe Capital Management’s Calidi Biotherapeutics CLDI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,338	Closed	-$3.98M	–	1191
2022 Q2	$3.98M	Buy	3,338 +1	+0%	+$1.19K	0.09%	370
2022 Q1	$3.96M	Buy	3,337 +4	+0.1%	+$4.75K	0.09%	347
2021 Q4	$3.93M	Buy	+3,333	New	+$3.93M	0.1%	285